Evaluation of a nasopharyngeal stent in patients with obstructive sleep-related breathing disorders. Issue 1 (January 2022)

• Record Type: Journal Article
• Authors: Dellweg, Alexander; Kampmann, Martin; Tschopp, Kurt
• Is Part Of: Journal of international medical research. Volume 50:Issue 1(2022)
• Publication Date: 2022-01
• Subjects: Obstructive sleep apnea syndrome -- nasopharyngeal tube -- Naśtent -- drug-induced sleep endoscopy -- split-night examination -- peripheral arterial tonometry; Medicine -- Periodicals; Pharmacology -- Periodicals; 610.5
• DOI: 10.1177/03000605211073302
• Languages: English
• ISSNs: 0300-0605

Abstract

Objective: This study was performed to evaluate the therapeutic effect and diagnostic value of a novel nasopharyngeal stent (Naśtent; Corinium Medical Equipment Ltd., Cirencester, UK). The Naśtent is designed to stent palatal collapse in patients with sleep-related breathing disorders. Methods: The study was conducted from 2018 to 2019. Patients who did not qualify for continuous positive airway pressure therapy underwent split-night examination with an inserted Naśtent for the first half of the night. The next morning, drug-induced sleep endoscopy (DISE) was performed. Results: Of the 122 enrolled patients, 21 were excluded because of Naśtent intolerance (n = 14) or technically invalid examinations (n = 7). Among the remaining 101 patients, in correlation with DISE, the apnea–hypopnea index was significantly reduced in patients with palatal obstructions, mainly in those with anteroposterior collapse patterns. The Naśtent did not influence retrolingual or multilevel obstructions. Using a 40% reduction of the apnea–hypopnea index by the Naśtent as a cut-off value, 85.7% of soft palate obstructions were detected compared with DISE. Conclusions: The Naśtent is a viable tool to reduce palatal obstructions, although it is not readily tolerated. It may also be helpful for diagnosis of sleep-related breathing disorders when DISE is unavailable.